Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. | Int J Mol Sci | 2022 | 36555728 | PubTator, text mining | PubMed |
| The N6-Methyladenosine Regulator ALKBH5 Mediated Stromal Cell-Macrophage Interaction via VEGF Signaling to Promote Recurrent Spontaneous Abortion: A Bioinformatic and In Vitro Study. | Int J Mol Sci | 2022 | 36555463 | PubTator, text mining | PubMed |
| A Combined Risk Score Model to Assess Prognostic Value in Patients with Soft Tissue Sarcomas. | Cells | 2022 | 36552841 | PubTator, text mining | PubMed |
| Toward Establishing an Ideal Adjuvant for Non-Inflammatory Immune Enhancement. | Cells | 2022 | 36552770 | PubTator, text mining | PubMed |
| Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods. | Biomolecules | 2022 | 36551164 | PubTator, text mining | PubMed |
| Picomolar or beyond Limit of Detection Using Molecularly Imprinted Polymer-Based Electrochemical Sensors: A Review. | Biosensors (Basel) | 2022 | 36551073 | PubTator, text mining | PubMed |
| High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells. | Front Immunol | 2022 | 36544780 | PubTator, text mining | PubMed |
| Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis. | Ann Transl Med | 2022 | 36544675 | PubTator, text mining | PubMed |
| Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma. | Sci Rep | 2022 | 36543847 | PubTator, text mining | PubMed |
| SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants. | Cell Discov | 2022 | 36543767 | PubTator, text mining | PubMed |
| m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine. | Front Immunol | 2022 | 36532062 | PubTator, text mining | PubMed |
| Immune related biomarkers for cancer metastasis to the brain. | Exp Hematol Oncol | 2022 | 36527157 | PubTator, text mining | PubMed |
| Machine learning links different gene patterns of viral infection to immunosuppression and immune-related biomarkers in severe burns. | Front Immunol | 2022 | 36518755 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. | PeerJ | 2022 | 36518297 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36518255 | PubTator, text mining | PubMed |
| Elucidating the Gene Signatures and Immune Cell Types in HIV-Infected Immunological Non-Responders by Bioinformatics Analyses. | Int J Gen Med | 2022 | 36514742 | PubTator, text mining | PubMed |
| Transcriptional mapping of the macaque retina and RPE-choroid reveals conserved inter-tissue transcription drivers and signaling pathways. | Front Genet | 2022 | 36506320 | PubTator, text mining | PubMed |
| Positive regulators of T cell proliferation as biomarkers for predicting prognosis and characterizing the immune landscape in lung adenocarcinoma. | Front Genet | 2022 | 36506303 | PubTator, text mining | PubMed |
| Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma. | Front Immunol | 2022 | 36505457 | PubTator, text mining | PubMed |
| Dysfunctional intercellular communication and metabolic signaling pathways in thin endometrium. | Front Physiol | 2022 | 36505055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=32